Serum markers of apoptosis in the early period of heart transplantation

References

• Arnau-Vives MA, Almenar L, Hervas I, Osa A, Martinez-Dolz L, Rueda J, Zorio E, Martinez-Ortiz De Urbina L, Perez JL, Mateo A, Palencia M. (2004). Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant 23:850–856.
   PubMed Web of Science ®Google Scholar
• Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A. (1990). A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 9:587–593.
   PubMedGoogle Scholar
• Carpio VN, Aquino-Dias EC, Prochnow TA, Manfro RC, Gonçalves LF. (2006). Evaluation of apoptosis in peripheral blood lymphocytes of renal transplant patients. Transplant Proc 38:1898–1900.
   PubMed Web of Science ®Google Scholar
• Chinnaiyan AM, O’Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM. (1996). Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274:990–992.
   PubMed Web of Science ®Google Scholar
• Chollet-Martin S, Depoix JP, Hvass U, Pansard Y, Vissuzaine C, Gougerot-Pocidalo MA. (1990). Raised plasma levels of tumor necrosis factor in heart allograft rejection. Transplant Proc 22:283–286.
   PubMed Web of Science ®Google Scholar
• Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, Fedson S, Fisher P, Gonzales-Stawinski G, Martinelli L, McGiffin D, Smith J, Taylor D, Meiser B, Webber S, Baran D, Carboni M, Dengler T, Feldman D, Frigerio M, Kfoury A, Kim D, Kobashigawa J, Shullo M, Stehlik J, Teuteberg J, Uber P, Zuckermann A, Hunt S, Burch M, Bhat G, Canter C, Chinnock R, Crespo-Leiro M, Delgado R, Dobbels F, Grady K, Kao W, Lamour J, Parry G, Patel J, Pini D, Towbin J, Wolfel G, Delgado D, Eisen H, Goldberg L, Hosenpud J, Johnson M, Keogh A, Lewis C, O’Connell J, Rogers J, Ross H, Russell S, Vanhaecke J; International Society of Heart and Lung Transplantation Guidelines. (2010). The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 29:914–956.
   PubMed Web of Science ®Google Scholar
• Cristóbal C, Segovia J, Alonso-Pulpón LA, Castedo E, Vargas JA, Martínez JC. (2010). Apoptosis and acute cellular rejection in human heart transplants. Rev Esp Cardiol 63:1061–1069.
   PubMed Web of Science ®Google Scholar
• Deswal A, Misra A, Bozkurt B. (2001). The role of anti-cytokine therapy in the failing heart. Heart Fail Rev 6:143–151.
   PubMedGoogle Scholar
• Kanoh M, Takemura G, Misao J, Hayakawa Y, Aoyama T, Nishigaki K, Noda T, Fujiwara T, Fukuda K, Minatoguchi S, Fujiwara H. (1999). Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 99:2757–2764.
   PubMed Web of Science ®Google Scholar
• Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. (2000). Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611–620.
   PubMed Web of Science ®Google Scholar
• Koch A, Roth W, Steffek TM, Dengler TJ, Haass M, Karck M, Sack FU, Schirmacher P, Schnabel PA. (2008). Impact of apoptosis in acute rejection episodes after heart transplantation: immunohistochemical examination of right ventricular myocardial biopsies. Transplant Proc 40:943–946.
   PubMed Web of Science ®Google Scholar
• Laguens RP, Meckert PM, Martino JS, Perrone S, Favaloro R. (1996). Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. J Heart Lung Transplant 15:911–918.
   PubMed Web of Science ®Google Scholar
• Masri SC, Yamani MH, Russell MA, Ratliff NB, Yang J, Almasan A, Apperson-Hansen C, Li J, Starling RC, McCarthy P, Young JB, Bond M. (2003). Sustained apoptosis in human cardiac allografts despite histologic resolution of rejection. Transplantation 76:859–864.
   PubMed Web of Science ®Google Scholar
• Masri SC, Yamani MH, Ratliff NB, Almasan A, Fink M, Young JB, Starling RC, Bond M. (2001). Apoptosis in cardiac allograft rejection and its response to treatment. J Heart Lung Transplant 20:227.
   PubMed Web of Science ®Google Scholar
• Nishigaki K, Minatoguchi S, Seishima M, Asano K, Noda T, Yasuda N, Sano H, Kumada H, Takemura M, Noma A, Tanaka T, Watanabe S, Fujiwara H. (1997). Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol 29:1214–1220.
   PubMed Web of Science ®Google Scholar
• Ohno M, Takemura G, Ohno A, Misao J, Hayakawa Y, Minatoguchi S, Fujiwara T, Fujiwara H. (1998). “Apoptotic” myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with In situ nick end-labeling. Circulation 98:1422–1430.
   PubMed Web of Science ®Google Scholar
• Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD. (2000). Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102:3060–3067.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. (2000). Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149–2153.
   PubMed Web of Science ®Google Scholar
• Siebels M, Hegele A, Varga Z, Oberneder R, Doehn C, Heinzer H; Deutsche GesellschaftfürImmun-und Targeted Therapiee. V. (DGFIT). Metastatic renal cell cancer in Germany in 2010: Impact of different target therapies. Urologe A. 2011 May 12.
   Google Scholar
• Song CJ, Liu XS, Zhu Y, Chen LH, Jia W, Li YN, Cao YX, Xie X, Zhuang R, Zhu CS, Jin BQ. (2004). Expression of TRAIL, DR4, and DR5 in kidney and serum from patients receiving renal transplantation. Transplant Proc 36:1340–1343.
   PubMed Web of Science ®Google Scholar
• Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI. (2010). The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report–2010. J Heart Lung Transplant 29:1089–1103.
   PubMed Web of Science ®Google Scholar
• Stoica SC, Cafferty F, Pauriah M, Taylor CJ, Sharples LD, Wallwork J, Large SR, Parameshwar J. (2006). The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. J Heart Lung Transplant 25:420–425.
   PubMed Web of Science ®Google Scholar
• Sun JP, Abdalla IA, Asher CR, Greenberg NL, Popovic ZB, Taylor DO, Starling RC, Thomas JD, Garcia MJ. (2005). Non-invasive evaluation of orthotopic heart transplant rejection by echocardiography. J Heart Lung Transplant 24:160–165.
   PubMed Web of Science ®Google Scholar
• Szabolcs M, Michler RE, Yang X, Aji W, Roy D, Athan E, Sciacca RR, Minanov OP, Cannon PJ. (1996). Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation 94:1665–1673.
   PubMed Web of Science ®Google Scholar
• Tanji N, Yokoyama M. (2011). Treatment of metastatic renal cell carcinoma and renal pelvic cancer. Clin Exp Nephrol 15:331–338.
   PubMed Web of Science ®Google Scholar
• Thaunat O, Morelon E. (2005). [Cancer and immunosuppression: pro- and antitumoral effects of immunosuppressive drugs]. Nephrol Ther 1:23–30.
   PubMedGoogle Scholar